Haptoglobin phenotype, sleep-disordered breathing, and the prevalence of cardiovascular disease: The Sleep Heart Health Study

Andrew P. Levy, Lin Zhang, Rachel Miller-Lotan, Susan Redline, George T. O'Connor, Stuart F Quan, Helaine E. Resnick

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Diabetes is an independent risk factor for cardiovascular disease, and there is growing evidence that sleep-disordered breathing also may increase the risk of cardiovascular disease. The mechanism responsible for increased susceptibility of people with diabetes to cardiovascular disease is thought to share several features with sleep-disordered breathing, notably increased oxidative stress. We recently demonstrated that a particular haptoglobin phenotype that is associated with differential antioxidant activity is an independent risk factor for cardiovascular disease in individuals with diabetes. We therefore sought to determine whether sleep-disordered breathing and cardiovascular disease are more strongly associated among people with the unfavorable haptoglobin phenotype. Methods: We tested this hypothesis in 2,612 middle-aged and older participants from the Sleep Heart Health Study. Haptoglobin phenotyping was performed by gel electrophoresis. Respiratory disturbance index was assessed by standard methods. Logistic regression analysis was performed to estimate the association between haptoglobin phenotype and cardiovascular disease, adjusting for known cardiovascular risk factors (age, sex, diabetes, smoking, lipid levels, and hypertension). Possible modification by haptoglobin phenotype of the association of sleep-disordered breathing with cardiovascular disease prevalence was explored by examining interaction terms. Results: We found no significant association between haptoglobin phenotype and prevalent cardiovascular disease in this cohort, nor were significant interactions found between haptoglobin phenotype and sleep-disordered breathing on the prevalence of cardiovascular disease. Conclusions: Sleep-disordered breathing did not appear to interact with haptoglobin phenotype in modifying the association with prevalent cardiovascular disease in the Sleep Heart Health Study. These findings could be due to the absence of association or to survivor bias in these cross-sectional analyses. Citation: Levy AP; Zhang L; Lotan RM et al. Haptoglobin phenotype, sleep-disordered breathing, and the prevalence of cardiovascular disease: the sleep heart health study.

Original languageEnglish (US)
Pages (from-to)207-213
Number of pages7
JournalSleep
Volume28
Issue number2
StatePublished - Feb 1 2005

Fingerprint

Haptoglobins
Sleep Apnea Syndromes
Sleep
Cardiovascular Diseases
Phenotype
Health
Survivors
Electrophoresis
Oxidative Stress
Cross-Sectional Studies
Antioxidants
Logistic Models
Smoking
Gels
Regression Analysis
Hypertension

ASJC Scopus subject areas

  • Physiology

Cite this

Levy, A. P., Zhang, L., Miller-Lotan, R., Redline, S., O'Connor, G. T., Quan, S. F., & Resnick, H. E. (2005). Haptoglobin phenotype, sleep-disordered breathing, and the prevalence of cardiovascular disease: The Sleep Heart Health Study. Sleep, 28(2), 207-213.

Haptoglobin phenotype, sleep-disordered breathing, and the prevalence of cardiovascular disease : The Sleep Heart Health Study. / Levy, Andrew P.; Zhang, Lin; Miller-Lotan, Rachel; Redline, Susan; O'Connor, George T.; Quan, Stuart F; Resnick, Helaine E.

In: Sleep, Vol. 28, No. 2, 01.02.2005, p. 207-213.

Research output: Contribution to journalArticle

Levy, AP, Zhang, L, Miller-Lotan, R, Redline, S, O'Connor, GT, Quan, SF & Resnick, HE 2005, 'Haptoglobin phenotype, sleep-disordered breathing, and the prevalence of cardiovascular disease: The Sleep Heart Health Study', Sleep, vol. 28, no. 2, pp. 207-213.
Levy AP, Zhang L, Miller-Lotan R, Redline S, O'Connor GT, Quan SF et al. Haptoglobin phenotype, sleep-disordered breathing, and the prevalence of cardiovascular disease: The Sleep Heart Health Study. Sleep. 2005 Feb 1;28(2):207-213.
Levy, Andrew P. ; Zhang, Lin ; Miller-Lotan, Rachel ; Redline, Susan ; O'Connor, George T. ; Quan, Stuart F ; Resnick, Helaine E. / Haptoglobin phenotype, sleep-disordered breathing, and the prevalence of cardiovascular disease : The Sleep Heart Health Study. In: Sleep. 2005 ; Vol. 28, No. 2. pp. 207-213.
@article{fb480f8331f54eb583e2f96060be1e79,
title = "Haptoglobin phenotype, sleep-disordered breathing, and the prevalence of cardiovascular disease: The Sleep Heart Health Study",
abstract = "Background: Diabetes is an independent risk factor for cardiovascular disease, and there is growing evidence that sleep-disordered breathing also may increase the risk of cardiovascular disease. The mechanism responsible for increased susceptibility of people with diabetes to cardiovascular disease is thought to share several features with sleep-disordered breathing, notably increased oxidative stress. We recently demonstrated that a particular haptoglobin phenotype that is associated with differential antioxidant activity is an independent risk factor for cardiovascular disease in individuals with diabetes. We therefore sought to determine whether sleep-disordered breathing and cardiovascular disease are more strongly associated among people with the unfavorable haptoglobin phenotype. Methods: We tested this hypothesis in 2,612 middle-aged and older participants from the Sleep Heart Health Study. Haptoglobin phenotyping was performed by gel electrophoresis. Respiratory disturbance index was assessed by standard methods. Logistic regression analysis was performed to estimate the association between haptoglobin phenotype and cardiovascular disease, adjusting for known cardiovascular risk factors (age, sex, diabetes, smoking, lipid levels, and hypertension). Possible modification by haptoglobin phenotype of the association of sleep-disordered breathing with cardiovascular disease prevalence was explored by examining interaction terms. Results: We found no significant association between haptoglobin phenotype and prevalent cardiovascular disease in this cohort, nor were significant interactions found between haptoglobin phenotype and sleep-disordered breathing on the prevalence of cardiovascular disease. Conclusions: Sleep-disordered breathing did not appear to interact with haptoglobin phenotype in modifying the association with prevalent cardiovascular disease in the Sleep Heart Health Study. These findings could be due to the absence of association or to survivor bias in these cross-sectional analyses. Citation: Levy AP; Zhang L; Lotan RM et al. Haptoglobin phenotype, sleep-disordered breathing, and the prevalence of cardiovascular disease: the sleep heart health study.",
author = "Levy, {Andrew P.} and Lin Zhang and Rachel Miller-Lotan and Susan Redline and O'Connor, {George T.} and Quan, {Stuart F} and Resnick, {Helaine E.}",
year = "2005",
month = "2",
day = "1",
language = "English (US)",
volume = "28",
pages = "207--213",
journal = "Sleep",
issn = "0161-8105",
publisher = "American Academy of Sleep Medicine",
number = "2",

}

TY - JOUR

T1 - Haptoglobin phenotype, sleep-disordered breathing, and the prevalence of cardiovascular disease

T2 - The Sleep Heart Health Study

AU - Levy, Andrew P.

AU - Zhang, Lin

AU - Miller-Lotan, Rachel

AU - Redline, Susan

AU - O'Connor, George T.

AU - Quan, Stuart F

AU - Resnick, Helaine E.

PY - 2005/2/1

Y1 - 2005/2/1

N2 - Background: Diabetes is an independent risk factor for cardiovascular disease, and there is growing evidence that sleep-disordered breathing also may increase the risk of cardiovascular disease. The mechanism responsible for increased susceptibility of people with diabetes to cardiovascular disease is thought to share several features with sleep-disordered breathing, notably increased oxidative stress. We recently demonstrated that a particular haptoglobin phenotype that is associated with differential antioxidant activity is an independent risk factor for cardiovascular disease in individuals with diabetes. We therefore sought to determine whether sleep-disordered breathing and cardiovascular disease are more strongly associated among people with the unfavorable haptoglobin phenotype. Methods: We tested this hypothesis in 2,612 middle-aged and older participants from the Sleep Heart Health Study. Haptoglobin phenotyping was performed by gel electrophoresis. Respiratory disturbance index was assessed by standard methods. Logistic regression analysis was performed to estimate the association between haptoglobin phenotype and cardiovascular disease, adjusting for known cardiovascular risk factors (age, sex, diabetes, smoking, lipid levels, and hypertension). Possible modification by haptoglobin phenotype of the association of sleep-disordered breathing with cardiovascular disease prevalence was explored by examining interaction terms. Results: We found no significant association between haptoglobin phenotype and prevalent cardiovascular disease in this cohort, nor were significant interactions found between haptoglobin phenotype and sleep-disordered breathing on the prevalence of cardiovascular disease. Conclusions: Sleep-disordered breathing did not appear to interact with haptoglobin phenotype in modifying the association with prevalent cardiovascular disease in the Sleep Heart Health Study. These findings could be due to the absence of association or to survivor bias in these cross-sectional analyses. Citation: Levy AP; Zhang L; Lotan RM et al. Haptoglobin phenotype, sleep-disordered breathing, and the prevalence of cardiovascular disease: the sleep heart health study.

AB - Background: Diabetes is an independent risk factor for cardiovascular disease, and there is growing evidence that sleep-disordered breathing also may increase the risk of cardiovascular disease. The mechanism responsible for increased susceptibility of people with diabetes to cardiovascular disease is thought to share several features with sleep-disordered breathing, notably increased oxidative stress. We recently demonstrated that a particular haptoglobin phenotype that is associated with differential antioxidant activity is an independent risk factor for cardiovascular disease in individuals with diabetes. We therefore sought to determine whether sleep-disordered breathing and cardiovascular disease are more strongly associated among people with the unfavorable haptoglobin phenotype. Methods: We tested this hypothesis in 2,612 middle-aged and older participants from the Sleep Heart Health Study. Haptoglobin phenotyping was performed by gel electrophoresis. Respiratory disturbance index was assessed by standard methods. Logistic regression analysis was performed to estimate the association between haptoglobin phenotype and cardiovascular disease, adjusting for known cardiovascular risk factors (age, sex, diabetes, smoking, lipid levels, and hypertension). Possible modification by haptoglobin phenotype of the association of sleep-disordered breathing with cardiovascular disease prevalence was explored by examining interaction terms. Results: We found no significant association between haptoglobin phenotype and prevalent cardiovascular disease in this cohort, nor were significant interactions found between haptoglobin phenotype and sleep-disordered breathing on the prevalence of cardiovascular disease. Conclusions: Sleep-disordered breathing did not appear to interact with haptoglobin phenotype in modifying the association with prevalent cardiovascular disease in the Sleep Heart Health Study. These findings could be due to the absence of association or to survivor bias in these cross-sectional analyses. Citation: Levy AP; Zhang L; Lotan RM et al. Haptoglobin phenotype, sleep-disordered breathing, and the prevalence of cardiovascular disease: the sleep heart health study.

UR - http://www.scopus.com/inward/record.url?scp=14944363527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14944363527&partnerID=8YFLogxK

M3 - Article

C2 - 16171245

AN - SCOPUS:14944363527

VL - 28

SP - 207

EP - 213

JO - Sleep

JF - Sleep

SN - 0161-8105

IS - 2

ER -